D.A. Davidson analyst D.A. Davidson maintained a Hold rating on Prestige Brand Holdings (NYSE:PBH) on Monday, setting a price target of $49, which is approximately 4.63% above the present share price of $46.83.
expects Prestige Brand Holdings to post earnings per share (EPS) of $0.81 for the second quarter of 2021.
The current consensus among 4 TipRanks analysts is for a Moderate Buy rating of shares in Prestige Brand Holdings, with an average price target of $53.
The analysts price targets range from a high of $57 to a low of $49.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $238.79 million and a net profit of $73.44 million. The company's market cap is $2.34 billion.
According to TipRanks.com, D.A. Davidson analyst D.A. Davidson is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 15.5% and a 61.24% success rate.
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare, and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.